DCC4118 |
Pgam1 Inhibitor Kh3 |
Novel allosteric PGAM1 inhibitor, showing efficacious in multiple preclinical models of pancreatic ductal adenocarcinoma (PDAC), especially with high PGAM1 expression |
|
DCC4119 |
Pge-2946979 |
Novel potent matrix metalloproteinase (MMP) inhibitor, targeting MMPs 1, 3, 9, and 13 (24, 18, 1.9, and 1.3 nM, respectively) |
|
DCC4120 |
Pgmi-004a |
Glycolytic enzyme phosphoglycerate mutase 1 (PGAM1) inhibitor |
|
DCC4122 |
pha-680626 |
Inhibitor of both Bcr-Abl tyrosine kinase and Aurora kinases |
|
DCC4123 |
Pha-e429 |
Selective ATP competitive ALK inhibitor |
|
DCC4124 |
Phagocytosis Inhibitor |
Inhibitor of phagocytosis, interacting with and inhibiting the activating Fc receptors on macrophages, inhibiting downstream signaling pathways driving Fc-mediated phagocytosis |
|
DCC4125 |
Phantasmidine |
Natural nicotinic acetylcholine receptor agonist |
|
DCC4126 |
Phar-095239 |
Novel COX-2 inhibitor |
|
DCC4127 |
Phencyclidine Hydrochloride |
Inhibitor of NMDA receptors, used as a veterinary anesthetic, and briefly as a general anesthetic for humans |
|
DCC4128 |
Phen-dc3 |
Selective ligand of a specific G-quadruplex conformation, interacting with the quadruplex through extensive |
|
DCC4129 |
phenoxodiol Diacetate |
Prodrug of phenoxodiol |
|
DCC4130 |
Phenylarsine Oxide |
Inhibitor of internalization of cell surface receptors and tyrosine phosphatases, with no effect on tyrosine kinase |
|
DCC4131 |
phenylmethimazole |
Blocker of dsRNA-induced IRF3 nuclear translocation and homodimerization; Inhibitor of lipopolysaccharide-mediated Toll-like receptor-4 signaling; Inhibitor of human pancreatic cancer |
|
DCC4132 |
Phnp-3 |
Novel selective α-syn ligand, exhibited the promising binding characteristics for α-syn aggregates (Ki = 0.52 nM) |
|
DCC4133 |
Phoenixin-14 |
Novel neuropeptide, protecting human brain vascular endothelial cells against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced inflammation and permeability, significantly ameliorating HFD-induced obesity and fatty liver, regulating pituitary gona |
|
DCC4134 |
Phoenixin-20 |
Novel GPR173 agonist, promoting osteoblastic differentiation of MC3T3-E1 cells. stimulating mRNAs encoding hypothalamo-pituitary-gonadal hormones |
|
DCC4135 |
Phomoxanthone A |
Natural anti-tumor agent, showing strong apoptotic anticancer effects against platinum-resistant solid cancers |
|
DCC4136 |
Phosphatidylinositol |
Potent antagonist of (H1N1)pdm09 infection, markedly suppressing cytopathic effects and attenuating viral gene expression in (H1N1)pdm09-infected MDCK cells |
|
DCC4137 |
phospho-sulindac |
Sulindac derivative with promising anticancer activities |
|
DCC4138 |
Phosphotyrosine |
Inducer of platelet aggregation, playing a role in cellular signal transduction and possibly in cell growth control and carcinogenesis |
|
DCC4139 |
Photac-i-3 |
Novel photoswitchable BET bromodomain Degrader (PHOTAC) |
|
DCC4140 |
Photoazolol-1 |
Novel potent photoswitchable antagonist for a precise spatiotemporal control of β2-adrenoceptors |
|
DCC4141 |
Photogbi1 |
Novel photocontrol inhibitor of the voltage-gated proton channel Hv1 |
|
DCC4142 |
Photo-lenalidomide-acid |
Functionalized photoswitchable cereblon ligand for Degraders |
|
DCC4143 |
Photos1p |
Novel photoswitchable sphingolipid probe, reversibly controlled S1P3-dependent pain hypersensitivity in mice and uniquely suited for the study of S1P biology in cultured cells and in vivo |
|
DCC4144 |
Photosensitizer Pz I |
Novel porphyrazine-based photodynamic anti-cancer agent, inducing immunogenic cell death |
|
DCC4145 |
Photosensitizer Pz Iii |
Novel porphyrazine-based photodynamic anti-cancer agent, inducing immunogenic cell death |
|
DCC4146 |
Photosph |
Novel photoswitchable sphingolipid probe |
|
DCC4147 |
Phototrexate |
Novel photoswitchable inhibitor of human dihydrofolate reductase |
|
DCC4148 |
Phyllospadine |
Natural flavonoidal alkaloid from the sea-grass Phyllosphadix iwatensis |
|